v3.21.2
Segment Information
9 Months Ended
Sep. 30, 2021
Segment Information  
Segment Information

Note 15. Segment Information

The Company analyzes the results of the Company’s business through the Company’s three reportable segments: XpresSpa™, XpresTest™, and Treat™. The XpresSpa segment provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products. The XpresTest segment provides diagnostic COVID-19 tests at XpresCheck™ Wellness Centers in airports, to airport employees and to the traveling public.  The Treat™ segment provides access to integrated care which can seamlessly fit into a post-pandemic world and is designed to deliver on-demand access to integrated healthcare through technology and personalized services, positioned for a traveler to access health care, records and real-time information all in one place, as well as book appointments in the Company’s on-site wellness centers as they reopen. The chief operating decision maker evaluates the operating results and performance of the Company’s segments through operating income. Expenses that can be specifically identified with a segment have been included as deductions in determining operating income. Any remaining expenses and other charges are included in Corporate and Other.

For the three months ended

September 30, 

    

2021

    

2020

Revenue

 

  

 

  

XpresSpaTM

$

1,415

$

140

XpresTestTM

25,351

TreatTM

Corporate and other

 

 

61

Total revenue

$

26,767

$

201

Operating income (loss)

 

  

 

  

XpresSpaTM

$

(1,595)

$

(5,699)

XpresTestTM

12,015

(1,791)

TreatTM

(2,305)

Corporate and other

 

(1,058)

 

(1,733)

Total operating income (loss)

$

7,057

$

(9,223)

For the nine months ended

September 30, 

    

2021

    

2020

Revenue

 

  

 

  

XpresSpaTM

$

2,172

$

7,729

XpresTestTM

42,199

TreatTM

Corporate and other

 

 

333

Total revenue

$

44,371

$

8,062

Operating income (loss)

 

  

 

  

XpresSpaTM

$

(4,828)

$

(16,103)

XpresTestTM

14,597

(1,791)

TreatTM

(4,115)

Corporate and other

 

(3,719)

 

(4,761)

Total operating income (loss)

$

1,935

$

(22,655)

September 30, 

September 30, 

2021

    

2020

Assets

 

  

 

  

XpresSpaTM

$

15,278

$

5,816

XpresTestTM

 

19,428

 

TreatTM

3,116

Corporate and other

 

91,455

 

75,713

Total assets

$

129,277

$

81,529